Detalles de la búsqueda
1.
A Phase III Study to Compare the Efficacy and Safety of Paclitaxel Versus Irinotecan in Patients with Metastatic or Recurrent Gastric Cancer Who Failed in First-line Therapy (KCSG ST10-01).
Oncologist
; 24(1): 18-e24, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30126861
2.
Correction to: The impact of caregiver's role preference on decisional conflicts and psychiatric distresses in decision making to help caregiver's disclosure of terminal disease status.
Qual Life Res
; 28(6): 1693, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30790153
3.
Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective study.
Br J Cancer
; 118(9): 1169-1175, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29576622
4.
Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG).
Gastric Cancer
; 21(5): 819-830, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29427038
5.
The impact of caregiver's role preference on decisional conflicts and psychiatric distresses in decision making to help caregiver's disclosure of terminal disease status.
Qual Life Res
; 27(6): 1571-1581, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29478132
6.
A phase II study of ifosfamide, methotrexate, etoposide, and prednisolone for previously untreated stage I/II extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial of the Korean Cancer Study Group.
Oncologist
; 19(11): 1129-30, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25280488
7.
A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer.
Invest New Drugs
; 32(3): 561-8, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24573743
8.
Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trial.
Invest New Drugs
; 32(4): 753-61, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24715580
9.
Noninterventional observational study using high-dose controlled-release oxycodone (CR oxycodone) for cancer pain management in outpatient clinics.
Pain Med
; 14(12): 1866-72, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24010556
10.
Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01): an open-label, phase 3 trial.
Cancer
; 118(24): 6234-42, 2012 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22674612
11.
A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research.
Invest New Drugs
; 30(3): 1164-74, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21404106
12.
Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study.
Acta Oncol
; 51(4): 528-36, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22150077
13.
Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6.
Cancer Sci
; 101(3): 793-9, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20047592
14.
Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib.
Ann Hematol
; 89(7): 725-31, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20179930
15.
Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy.
Clin Cancer Res
; 15(6): 2107-15, 2009 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19276283
16.
The dosing frequency of sustained-release opioids and the prevalence of end-of-dose failure in cancer pain control: a Korean multicenter study.
Support Care Cancer
; 19(2): 297-301, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20213238
17.
Are there any ethnic differences in molecular predictors of erlotinib efficacy in advanced non-small cell lung cancer?
Clin Cancer Res
; 14(12): 3860-6, 2008 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18559606
18.
Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer.
Cancer Res Treat
; 51(1): 223-239, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30584995
19.
A phase II study of biweekly irinotecan and cisplatin for patients with extensive stage disease small cell lung cancer.
Lung Cancer
; 59(1): 76-80, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17767977
20.
A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer.
Cancer Chemother Pharmacol
; 62(5): 763-8, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18172648